Research Archives
Blood test figures in cancer risk for people with HIV
Mar. 17, 2022—A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.
Discovery Lecture featuring Sánchez Alvarado returns to in-person format
Mar. 17, 2022—Alejandro Sánchez Alvarado, PhD, executive director and chief scientific officer of the Stowers Institute for Medical Research in Kansas City, Missouri, will discuss tissue regeneration at the next Discovery Lecture, in person on Thursday, March 24 in 208 Light Hall.
Improving care for gynecologic cancer
Mar. 15, 2022—To reduce risk of deep vein thrombosis in patients being treated for gynecologic cancer, Vanderbilt researchers recommend that providers use Khorana scores and provide prophylactic treatment according to clinical guidelines.
Microbiome reflects COVID-19 severity
Mar. 14, 2022—Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered.
Bots boost liver cancer outcome
Mar. 10, 2022—Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients.
Technique hastens COVID-19 antibody discovery
Mar. 10, 2022—Optimization of a technique developed at Vanderbilt University Medical Center enables rapid and efficient identification of neutralizing monoclonal antibodies against the virus that causes COVID-19.
Brain function expert Deisseroth set for March 17 Discovery Lecture
Mar. 10, 2022—Optogenetics pioneer Karl Deisseroth, MD, PhD, will speak at Vanderbilt's upcoming Discovery Lecture on Thursday, March 17.
Research Staff Awards honor those who help drive science forward
Mar. 9, 2022—Laboratory and administrative personnel at Vanderbilt University Medical Center were honored March 4 for research excellence during the 18th annual Research Staff Awards Ceremony.
Former Karolinska Institute chair Norrby set for March 14 lecture
Mar. 8, 2022—Erling Norrby, MD, PhD, a world authority on viruses and former chair at the Karolinska Institute in Stockholm, Sweden, will deliver a lecture at Vanderbilt University Medical Center on Monday, March 14.
Study finds World Trade Center responders at higher risk for blood cancer-associated mutations
Mar. 7, 2022—A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease
Probing cancer cell invasion
Mar. 1, 2022—The rigidity of the extracellular matrix that surrounds cells impacts the contractile and invasive properties of head and neck cancer cells.
Invasive strep can defy zinc toxicity
Feb. 28, 2022—Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.
